Tokai Pharmaceuticals and Otic Pharma Enter into Share Purchase AgreementShare Purchase Agreement • November 8th, 2023
Contract Type FiledNovember 8th, 2023Transaction to create NASDAQ-listed pharmaceutical company focused on the development and commercialization of ear, nose, and throat (ENT) products